Blog

Shilpa Gupta: Global impact of IBCG Bladder Cancer discussed at GUInc Retreat

Shilpa Gupta/X

Dec 16, 2024, 17:22

Shilpa Gupta: Global impact of IBCG Bladder Cancer discussed at GUInc Retreat

Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, posted the following on X:

“Such an inspiring talk by Ashish M. Kamat on the birth and evolution of his brainchild IBCG Bladder Cancer and its wide global impact at the Ospedale San Raffaele GUInc Retreat organized by Andrea Necchi. So fortunate to be a part of this tremendous global organization.”

Dr. Shilpa Gupta is the Director of Genitourinary Oncology, a staff member in Hematology and Oncology and a Professor of Medicine at Cleveland Clinic. Dr. Gupta’s extensive research focuses on novel drug development and biomarkers of response/resistance in bladder cancer, contributing to numerous published works and leadership roles in clinical trials.

Andrea Necchi Ashish M. Kamat bladder cancer cancer Cancer research clinical leadership global impact GU cancers GUInc Retreat IBCG Bladder Cancer OncoDaily Oncology oncology collaboration San Raffaele MI Shilpa Gupta UroDocAsh urologic oncology

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage